Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

AACR Pancreatic Cancer: Progress and Challenges

The American Association for Cancer Research held a special conference on Pancreatic Cancer: Progress and Challenges, bringing together world renowned researchers in the discussion on how to diagnose and treat this devastating disease.

The AACR's Pancreatic Cancer Meeting was a great forum for researchers and clinicians to consider the progress and challenges of pancreatic cancer research. Internationally renowned speakers presented new ideas and findings as the worlds pancreatic cancer researchers joined together to discuss these 8 major questions shaping the conference:
Can we diagnose pancreatic cancer early?
Can pancreatic cancer be avoided?
How does pancreatic cancer develop?
Why does pancreatic cancer metastasize and cause cachexia and pain?
How does the tumour microenvironment influence pancreatic cancer?
Can KRAS be defeated?
What are the promising preclinical and clinical advances in pancreatic cancer?
Are there new ways to prevent or treat pancreatic cancer?

Andrew Biankin, co-head of the APGI, presented some of our research findings as he discussed the roles of chromatin modification and axon guidance in pancreatic cancer as revealed by genomic analysis.

For more information and to read recently published journal articles on these topics visit the